Document Detail

What is new in atopic dermatitis/eczema?
MedLine Citation:
PMID:  25286776     Owner:  NLM     Status:  Publisher    
Introduction: Atopic eczema (AE) is a chronic relapsing inflammatory skin condition and one of the most common, potentially debilitating diseases with increasing incidence. Areas covered: The complex etiology of AE with multiple systemic and local immunologic and inflammatory responses and interactions between susceptibility genes and environmental factors leading to defects in skin barrier function and eczematous skin lesions is presented. Knowledge of pathogenesis is important for understanding the more innovative treatment approaches discussed. Expert opinion: Basic therapy consists of hydrating topical treatment and avoidance of specific and unspecific provocation factors. For acute eczematous skin lesions, anti-inflammatory treatment consists mainly of topical glucocorticoids and topical calcineurin inhibitors. Microbial colonization and superinfection may induce skin exacerbation, which can be treated by either topical or systemic antimicrobial treatment. Systemic anti-inflammatory therapy is limited to severe cases and consists of systemic steroids, cyclosporine A or mycophenolate mofetil. Novel anti-inflammatory concepts that go beyond corticosteroids are in the early phases of development. There are targeted therapeutic approaches, such as cytokine and chemokine modulators, and it remains to be investigated how effective they will be and what side effects they may carry. Existing treatment modalities such as barrier repair therapy, topical immunosuppressive agents, antiseptic treatment as well as systemic treatment options are discussed.
Sabine G Plötz; Markus Wiesender; Antonia Todorova; Johannes Ring
Related Documents :
17019166 - Anaesthetics and immune function.
3114846 - Inhibition of carrageenin-induced pedal oedema in rats by immobilisation stress.
3910116 - Biofeedback-assisted relaxation: effects on phagocytic capacity.
16413386 - Acetylsalicylic acid-induced release of hsp70 from mast cells results in cell activatio...
23151036 - Nitric oxide and superoxide mediate diesel particle effects in cytokine-treated mice an...
25315216 - Protease iv, a quorum sensing-dependent protease of pseudomonas aeruginosa modulates in...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-10-7
Journal Detail:
Title:  Expert opinion on emerging drugs     Volume:  -     ISSN:  1744-7623     ISO Abbreviation:  Expert Opin Emerg Drugs     Publication Date:  2014 Oct 
Date Detail:
Created Date:  2014-10-7     Completed Date:  -     Revised Date:  2014-10-8    
Medline Journal Info:
Nlm Unique ID:  101135662     Medline TA:  Expert Opin Emerg Drugs     Country:  -    
Other Details:
Languages:  ENG     Pagination:  1-18     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Calcium micro-depositions in jugular truncular venous malformations revealed by Synchrotron-based XR...
Next Document:  Core needle biopsy is a safe and accurate initial diagnostic procedure for suspected lymphoma.